Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 3 years.
Arrowhead Pharmaceuticals Inc.
Director
Tonix Pharmaceuticals Holding Corp.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −3,090 | $66.70 | $206,103 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −6,083 | $68.04 | $413,887 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −827 | $68.48 | $56,633 |
| Dec 16, 2025 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,819 | — | — |
| Jan 23, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −959 | $21.00 | $20,139 |
| Dec 27, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −2,850 | $20.00 | $57,000 |
| Dec 18, 2024 | Arrowhead Pharmaceuticals Inc. | Grant or award | +16,733 | $22.99 | $384,692 |
| Jun 10, 2024 | Tonix Pharmaceuticals Holding Corp. | Other | −1 | $1.91 | $2 |
| Dec 15, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +14,987 | $25.41 | $380,820 |
| Mar 3, 2023 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −11,350 | $32.65 | $370,578 |
| Jan 10, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,867 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.